Literature DB >> 19844221

Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function.

W J Spruill1, W E Wade, H H Cobb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19844221     DOI： 10.1038/clpt.2009.187

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

1.  Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.

Authors:  Solène M Laville; Marie Metzger; Bénédicte Stengel; Christian Jacquelinet; Christian Combe; Denis Fouque; Maurice Laville; Luc Frimat; Carole Ayav; Elodie Speyer; Bruce M Robinson; Ziad A Massy; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2018-09-24       Impact factor: 4.335

2.  Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients.

Authors:  Manjunath P Pai; Anne N Nafziger; Joseph S Bertino
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

3.  Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.

Authors:  Nishank Jain; Robert F Reilly
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-25       Impact factor: 8.237

4.  Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C.

Authors:  Paul K L Chin; Daniel F B Wright; Mei Zhang; Mary C Wallace; Rebecca L Roberts; David M Patterson; Berit P Jensen; Murray L Barclay; Evan J Begg
Journal:  Drugs R D       Date:  2014-06

5.  Potentially inappropriate prescribing of primarily renally cleared medications for older veterans affairs nursing home patients.

Authors:  Joseph T Hanlon; Xiaoqiang Wang; Steven M Handler; Steven Weisbord; Mary Jo Pugh; Todd Semla; Roslyn A Stone; Sherrie L Aspinall
Journal:  J Am Med Dir Assoc       Date:  2010-10-02       Impact factor: 4.669

6.  Warfarin dosing in patients with impaired kidney function.

Authors:  Nita A Limdi; Mohit A Limdi; Larisa Cavallari; Aaron M Anderson; Michael R Crowley; Melissa F Baird; Michael Allon; T Mark Beasley
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

Review 7.  Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review.

Authors:  Willemijn L Eppenga; Cornelis Kramers; Hieronymus J Derijks; Michel Wensing; Jack F M Wetzels; Peter A G M De Smet
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

8.  Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly.

Authors:  Anders Helldén; Ingegerd Odar-Cederlöf; Göran Nilsson; Susanne Sjöviker; Anders Söderström; Mia von Euler; Gunnar Ohlén; Ulf Bergman
Journal:  BMJ Open       Date:  2013-04-11       Impact factor: 2.692

9.  Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment--a comparative study.

Authors:  M Angeles Via-Sosa; Natali Lopes; Marian March
Journal:  BMC Fam Pract       Date:  2013-07-13       Impact factor: 2.497
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.